{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:41Z","timestamp":1790746781951,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"11","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Cancer develops through the interactions between cancer stem cells and components of the tumor microenvironment (TME). To model in vivo cancer stem cell\u2013TME interactions and elucidate their functional consequences, we focused on myelofibrosis (MF), a stem cell\u2013driven myeloproliferative neoplasm. We cocultured MF hematopoietic stem and progenitor cells (HSPCs) with normal donor endothelial cells (ECs) and mesenchymal stromal cells (MSCs) to investigate the consequences of interactions between malignant MF HSPCs and nonmalignant microenvironmental cells. This tricultivation system proved to be a simple and reproducible platform, which promoted malignant clone dominance and the persistence of MF HSPCs that recapitulate the MF phenotype upon transplantation into immunodeficient mice, including splenomegaly and marrow fibrosis. Transcriptional profiling revealed extensive reprogramming of not only the cocultured MF HSPCs, but also MSCs and ECs. Although numerous disease-relevant pathways were upregulated, the proinflammatory response stood out as a key consequence of MF HSPC\u2013TME interactions. We validated these findings through quantitation of proinflammatory transcript upregulation and cytokine production. This human multicellular model system has proven useful in demonstrating the multidirectional interactions of MF HSPCs with TME cells that are essential for sustaining fully functional MF stem cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031454","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:10:47Z","timestamp":1765836647000},"page":"1215-1228","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cells"],"prefix":"10.1182","volume":"147","author":[{"given":"Min","family":"Lu","sequence":"first","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0372-9310","authenticated-orcid":false,"given":"M. Babu","family":"Mia","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xia","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohar","family":"Mosoyan","sequence":"additional","affiliation":[{"name":"2Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momina","family":"Hayat","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-4858","authenticated-orcid":false,"given":"Christoph","family":"Schaniel","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Medical Oncology, Tisch Cancer Institute and Department of Medicine, Myeloproliferative Neoplasm Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2026031211220510900_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41375-019-0379-y","article-title":"Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF-kB signaling","volume":"33","author":"Fisher","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"2026031211220510900_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.hoc.2020.11.003","article-title":"The Microenvironment in myeloproliferative neoplasms","volume":"35","author":"Ramanathan","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2026031211220510900_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hoc.2020.12.001","article-title":"Overview of myeloproliferative neoplasms: history, pathogenesis, diagnostic criteria, and complications","volume":"35","author":"Tremblay","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"2026031211220510900_bib4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026031211220510900_bib5","doi-asserted-by":"crossref","first-page":"906698","DOI":"10.3389\/fonc.2022.906698","article-title":"Megakaryocytes are regulators of the tumor microenvironment and malignant hematopoietic progenitor cells in myelofibrosis","volume":"12","author":"Varricchio","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"2026031211220510900_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/bloodadvances.2017015073","article-title":"The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis","volume":"2","author":"Qiu","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"2026031211220510900_bib7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s43018-023-00607-x","article-title":"Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms","volume":"4","author":"Grockowiak","year":"2023","journal-title":"Nat Cancer"},{"issue":"6","key":"2026031211220510900_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood.2024027455","article-title":"Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24","volume":"146","author":"Khatib-Massalha","year":"2025","journal-title":"Blood"},{"issue":"4","key":"2026031211220510900_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ccell.2018.03.024","article-title":"Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"issue":"9","key":"2026031211220510900_bib10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cells9092136","article-title":"Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants","volume":"9","author":"Masselli","year":"2020","journal-title":"Cells"},{"issue":"12","key":"2026031211220510900_bib11","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/2159-8290.CD-20-1652","article-title":"A humanized animal model predicts clonal evolution and therapeutic vulnerabilities in myeloproliferative neoplasms","volume":"11","author":"Celik","year":"2021","journal-title":"Cancer Discov"},{"issue":"3","key":"2026031211220510900_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.blre.2016.11.004","article-title":"Modeling myeloproliferative neoplasms: from mutations to mouse models and back again","volume":"31","author":"Morotti","year":"2017","journal-title":"Blood Rev"},{"issue":"20","key":"2026031211220510900_bib13","first-page":"2508","article-title":"CXCL8\/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis","volume":"141","author":"Dunbar","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2026031211220510900_bib14","doi-asserted-by":"crossref","first-page":"e70185","DOI":"10.1002\/hem3.70185","article-title":"Mesenchymal stromal cells from JAK2V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo","volume":"9","author":"Ferrelli","year":"2025","journal-title":"Hemasphere"},{"issue":"2","key":"2026031211220510900_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/2159-8290.CD-22-0199","article-title":"Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies","volume":"13","author":"Khan","year":"2023","journal-title":"Cancer Discov"},{"issue":"10","key":"2026031211220510900_bib16","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/nprot.2017.088","article-title":"Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice","volume":"12","author":"Reinisch","year":"2017","journal-title":"Nat Protoc"},{"issue":"7","key":"2026031211220510900_bib17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.4103","article-title":"A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells","volume":"22","author":"Reinisch","year":"2016","journal-title":"Nat Med"},{"issue":"11","key":"2026031211220510900_bib18","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1172\/JCI64397","article-title":"Spleens of myelofibrosis patients contain malignant hematopoietic stem cells","volume":"122","author":"Wang","year":"2012","journal-title":"J Clin Invest"},{"key":"2026031211220510900_bib19","doi-asserted-by":"crossref","first-page":"683401","DOI":"10.3389\/fimmu.2021.683401","article-title":"Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms","volume":"12","author":"Fisher","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"2026031211220510900_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2020.11.004","article-title":"Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis","volume":"28","author":"Leimkuhler","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2026031211220510900_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"8","key":"2026031211220510900_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2014-12-618595","article-title":"Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells","volume":"126","author":"Lu","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2026031211220510900_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/biom13010089","article-title":"Assessment of fibrinogen-like 2 (FGL2) in human chronic kidney disease through transcriptomics data analysis","volume":"13","author":"Denicol\u00f2","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"2026031211220510900_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41420-021-00437-9","article-title":"Role of interleukins in the pathogenesis of pulmonary fibrosis","volume":"7","author":"She","year":"2021","journal-title":"Cell Death Discov"},{"issue":"12","key":"2026031211220510900_bib25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00277-022-05001-8","article-title":"Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels","volume":"101","author":"Lewandowski","year":"2022","journal-title":"Ann Hematol"},{"issue":"5","key":"2026031211220510900_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"3","key":"2026031211220510900_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.molcel.2020.04.008","article-title":"Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets","volume":"78","author":"Psaila","year":"2020","journal-title":"Mol Cell"},{"issue":"6","key":"2026031211220510900_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1+ mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2026031211220510900_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1182\/blood-2016-12-757344","article-title":"Hmga2 promotes the development of myelofibrosis in Jak2V617F knockin mice by enhancing TGF-\u03b21 and Cxcl12 pathways","volume":"130","author":"Dutta","year":"2017","journal-title":"Blood"},{"issue":"18","key":"2026031211220510900_bib30","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.2019004095","article-title":"Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN","volume":"136","author":"Gleitz","year":"2020","journal-title":"Blood"},{"issue":"17","key":"2026031211220510900_bib31","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.3390\/cancers15174323","article-title":"Revisiting circulating extracellular matrix fragments as disease markers in myelofibrosis and related neoplasms","volume":"15","author":"Hasselbalch","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2026031211220510900_bib32","doi-asserted-by":"crossref","first-page":"nwae231","DOI":"10.1093\/nsr\/nwae231","article-title":"Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers","volume":"11","author":"Li","year":"2024","journal-title":"Natl Sci Rev"},{"issue":"768","key":"2026031211220510900_bib33","doi-asserted-by":"crossref","first-page":"eadj7552","DOI":"10.1126\/scitranslmed.adj7552","article-title":"A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"issue":"9","key":"2026031211220510900_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","article-title":"Immunomodulation by endothelial cells - partnering up with the immune system?","volume":"22","author":"Amersfoort","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"2026031211220510900_bib35","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1200\/JCO.2005.09.021","article-title":"Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia","volume":"23","author":"Massa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026031211220510900_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1084\/jem.20161616","article-title":"CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment","volume":"214","author":"Blaser","year":"2017","journal-title":"J Exp Med"},{"issue":"5","key":"2026031211220510900_bib37","doi-asserted-by":"crossref","first-page":"112528","DOI":"10.1016\/j.celrep.2023.112528","article-title":"Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C","volume":"42","author":"Binder","year":"2023","journal-title":"Cell Rep"},{"issue":"3","key":"2026031211220510900_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5495\/wjcid.v3.i3.37","article-title":"Physiological functions and clinical implications of fibrinogen-like 2: a review","volume":"3","author":"Yang","year":"2013","journal-title":"World J Clin Infect Dis"},{"issue":"1","key":"2026031211220510900_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jth.13191","article-title":"Actions of thrombin in the interstitium","volume":"14","author":"de Ridder","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026031211220510900_bib40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12967-023-04393-z","article-title":"Fibrosis and bone marrow: understanding causation and pathobiology","volume":"21","author":"Ghosh","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"2026031211220510900_bib41","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/s41467-025-60019-6","article-title":"Efficacy of JAK1\/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling","volume":"16","author":"Gorantla","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"2026031211220510900_bib42","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41467-022-32927-4","article-title":"Inhibition of interleukin-1\u03b2 reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm","volume":"13","author":"Rai","year":"2022","journal-title":"Nat Commun"},{"issue":"4-5","key":"2026031211220510900_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diff.2010.07.004","article-title":"Role of NFKB2 on the early myeloid differentiation of CD34+ hematopoietic stem\/progenitor cells","volume":"80","author":"De Molfetta","year":"2010","journal-title":"Differentiation"},{"issue":"14","key":"2026031211220510900_bib44","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","article-title":"S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","volume":"129","author":"Laouedj","year":"2017","journal-title":"Blood"},{"issue":"7512","key":"2026031211220510900_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"issue":"13","key":"2026031211220510900_bib46","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026031211220510900_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12890-024-03260-x","article-title":"IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN\/AKT\/ERK pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pulm Med"},{"issue":"4","key":"2026031211220510900_bib48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/wound.2019.1032","article-title":"The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis","volume":"9","author":"Steen","year":"2020","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"26","key":"2026031211220510900_bib49","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood.2022017326","article-title":"IL-13\/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms","volume":"140","author":"Melo-Cardenas","year":"2022","journal-title":"Blood"},{"issue":"6","key":"2026031211220510900_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"issue":"12","key":"2026031211220510900_bib51","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/11\/1215\/2508948\/blood_bld-2025-031454-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/11\/1215\/2508948\/blood_bld-2025-031454-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:22:20Z","timestamp":1773328940000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/11\/1215\/557335\/Microenvironmental-cell-interactions-are-essential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,3,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031454","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,12]]},"published":{"date-parts":[[2026,3,12]]}}}